Abstract:BACKGROUND: Vascular endothelial growth factor (VEGF) can specifically promote the division and proliferation of endothelial cells and the revascularization, finally induce angiopoiesis. Recently, VEGF-based gene therapy has been gradually used in clinical trials, but some limits on usually used vectors deserve further studies, including the low transfection efficiency of plasmid vector, the immunogenicity of adnovirus vector to host cells and the potential risk of infection. OBJECTIVE: To construct the non-pathogenic recombinant adeno-associated vires (AAV) co-expressing human vascular endethelial growth factor 165 (hVEGF165) and green fluorescent protein (GFP) label and measure the virus titer and assess its biological activity.DESIGN, TIME AND SETTING: The open experiment was performed at the Vitrus Laboratory of Shanxi Provincial Center for Disease Control and Prevention from March to September 2007.MATERIALS: AAV-293 virus packaging cell line, AAV HT-1080 cells were purchased from Swatagene, USA. E.coli DH5α was a stocked strain from Shanxi Provincial Center for Disease Control and Prevention. AAV Helper Free System (pAAV-IRES-GFP vector containing GFP label) was purchased from Stratagene, USA. Plasmid pUC18-hVEGF165 was constructed previously by Dr.Shi from Department of Orthopaedics of Second Affiliated Hospital of Xi'an Jiaotong University.METHODS: The hVEGF165 gone from plasmid pUC18-hVEGF165 was amplified and inserted into plasmid pAAV-IRES-hrGFP. Then recombinant plasmid pAAV-hVEGF165-IRES-hrGFP, pAAV-RC and pAAV-Helper were co-transfected into AAV-293 cells to complete rAAV-hVEGF165-IRES-hrGFP packaging through homologous recombination. The efficiency of A.AV packaging was monitored under a fluorescent microscope, and the recombinant viral particles were harvested from infected AAV-293 cells and further concentrated and purified. The recombinant virus infected the AAV-HT1080 cells, the virus titer was measured by fluorescence counting, and the recombinant AAV-hVEGF165-IRES-hrGFP was verified by the amplification of the exogenous gene of hVEGF165 from virus genome.MAIN OUTCOME MEASURES: Virus packaging efficiency was monitored under the fluorescence microscope. Virus filer was measured by fluorescent counting. The packaging of recombinant virus was determined by the amplification of the exogenous hVEGF165 gene.RESULTS: The amplified products were verified as hVEGF165 gene by DNA sequencing, and the recombinant pAAV-hVEGF165-IRES-hrGFP was confirmed by double digestion. The system provided a high packaging ratio of over 95% and the purified recombinant virus had a high titer of 5.5×1011 vp/mL. The recombinant virus was confirmed by exogenous human VEGF165 gene from virus genome.CONCLUSION: The non-pathogenic rAAV-hVEGF165-GFP simultaneously carrying hVEGF165 and GFP 1abel is successfully constructed, with a high titer and satisfying biological activity.

Construction and identification of recombinant adeno-associated virus shuttle vector co-expressing nogo66-siRNA and nerve growth factor-β genes

[Construction and Identification of Recombinant Adeno-Associated Virus Shuttle Vector Expressing Nerve Growth Factor Beta Gene].

[Construction and Screening of Neurite Outgrowth Inhibitory 66 Eukaryotic Expression Vectors].

Establishment of an expression vector of NgR-specific siRNA

Construction and Identification of Lentiviral Vector Carrying Nerve Growth Factor Gene

Construction and Identification of Recombinant Adenovirus Vectors Expressing GFP and Human Vascular Endothelial Growth Factor Short Hairpin RNA

Construction and identification of a lentiviral vector for RNA interference of rat chondroitin sulfate peoteoglycan gene

Construction and identification of recombinant adenoviruses expressing neuroglobin

The Generation of the Vector of RNA Interference Targeting Nogo Receptor

Construction and Target Gene Expression of Recombinant Adenovirus Vectors Containing Vascular Endothelial Growth Factor 165 and Angiopoietin-1

Establishment of A Recombinant Adeno-Associated Virus Expressing Hvegf(165)

[Construction and Expression of Recombinant Adeno-Associated Virus Expressing Brain-Derived Neurotrophic Factor].

Construction of Aecombinant Human Beta-Nerve Growth Factor Adenorivus by Homologous Recombination in Bacteria

Construction and expression of recombinant eukaryotie expression vector human NGF-β gene in spinal cord-derived neural stem cells

Construction and Identification of Recombinant Adeno- Associated Virus Vector Co-Expressing Human Vascular Endothelial Growth Factor and Green Fluorescent Protein

Construction and expression of NGN3 and PAX4 double-gene modified adenovirus vectors

Inhibition of Nogo Expression to Promote Repair after Spinal Cord Injury

CONSTRUCTION AND IDENTIFICATION OF SHUTTLE PLASMID OF RECOMBINANT ADENOVIRAL VECTOR CARRYING RAT GDNF GENE

[Cloning of NEP1-40 Gene and Expression of Its Protein].

Construction and Identification of Lentiviral Expression Vector for Ngb Gene

Construction of neuregulin 1-small interference RNA lentivirus vector